✦ LIBER ✦

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

✍ Scribed by Bozzetti, C; Negri, F V; Lagrasta, C A; Crafa, P; Bassano, C; Tamagnini, I; Gardini, G; Nizzoli, R; Leonardi, F; Gasparro, D

Book ID: 109838746
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 370 KB
Volume: 104
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2011.121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of ER/PR and HER2 statuses in

Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment

✍ Jieqiong Liu; Heran Deng; Weijuan Jia; Yunjie Zeng; Nanyan Rao; Shunrong Li; Lia 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 413 KB

Comparison of HER-2 status determined by

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

✍ Yun Gong; Daniel J. Booser; Nour Sneige 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Accurate assessment of __HER‐2__ status is necessary prior to anti‐__HER‐2__ antibody (trastuzumab) therapy for metastatic breast carcinoma. However, controversy exists regarding whether to assess __HER‐2__ status in the primary tumor or in metastatic lesions. It is also

HER2 Status of Gastric Carcinoma and Cor

HER2 Status of Gastric Carcinoma and Corresponding Lymph Node Metastasis

✍ Fabio Pagni, Stefano Zannella, Susanna Ronchi, Cristina Garanzini, Biagio Eugeni 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 229 KB

Comparison of HER-2 overexpression in pr

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

✍ Zidan, J; Dashkovsky, I; Stayerman, C; Basher, W; Cozacov, C; Hadary, A 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Comparison of HER-2 Overexpression in Pr

Comparison of HER-2 Overexpression in Primary Breast Cancer and Metastatic Sites and Its Effect on Biological Targeting Therapy of Metastatic Disease

✍ Hayes, D.F. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Heterogeneous amplification of ERBB2 in

Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma

✍ Min A Kim; Hyuk-Joon Lee; Han-Kwang Yang; Yung-Jue Bang; Woo Ho Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 526 KB